Exclusif
Release Date
Episode 478: Prostate Cancer Working Group 4 (PCWG 4) criteria
Episode 477: Uromigos Japan - GU Oncology 2025を総括!
Episode 476: ASCO GU 2026 Preview
Episode 475: Depth of Response and Overall Survival for IO-based Regimens in mRCC: Results of an FDA Analysis
Episode 474: Uromigos Shorts - IO-refractory Urothelial Cancer